Jon Meyerle, MD
Jon H Meyerle, MD, Colonel, Army
Name: Jon H Meyerle, MD, Colonel, Army
Amputee Skin Care, Teledermatology, Immunodermatology, Melanoma
2005 - 2006 Fellowship, Immunodermatology, Johns Hopkins School of Medicine
2001 - 2004 Residency, Dermatology, Walter Reed Army Medical Center and National Naval Medical Center, National Capital Consortium
1999 - 2000 Internship, Internal Medicine, Walter Reed Army Medical Center, Washington, DC
1999 M.D., Yale University School of Medicine (Honors)
1995 A.B., Molecular Biology, Princeton University (Cum Laude)
Dr. Meyerle’s primary research interests are in the areas of standardized imaging and teledermatology, amputee skin care, melanoma and blistering skin diseases.
He is currently collaborating with DermSpectra on projects to evaluate the implementation of standardized, full-body skin imaging platforms in the Military Health System. This interest complements Dr. Meyerle’s clinical interests in Teledermatology and screening platforms for malignant melanoma.
Dr. Meyerle became interested in amputee skin care as a result of his interaction with amputees returning from the wars in Iraq and Afghanistan. One of his mentors, Dr. (COL-retired) Chuck Scoville is a strong advocate for amputees and directed the Military Advanced Training Center (MATC) at Walter Reed who encouraged him to pursue ways to address skin disease in this population.
Research in skin disease in amputees is important because over half of amputees develop skin disease at the stump site. This skin disease is often overlooked and not easy to treat. As a result, the amputee cannot wear the prosthesis or use more advanced prosthesis devices.
Since his arrival at USU, Dr. Meyerle has been developing a therapeutic to alter the skin identity at the amputee stump. The goal of this research is to allow the skin at the stump to take on the properties of skin found on the palms and soles.
In addition to research in amputee skin care, Dr. Meyerle also has an interest in better ways to diagnose melanoma. His research in melanoma focuses on the genetic and environmental risk factors for developing melanoma in military personnel. Melanoma is the most significant cancer to affect an active duty military population. It strikes young adults in their 20-40s and, if not diagnosed in time, is fatal.
As a trained immunodermatologist, Dr. Meyerle has a clinical interest in blistering diseases such as pemphigus and pemphigoid. Dr. Meyerle’s clinical interests in immunodermatology have been nurtured since fellowship by his mentor, Dr. Grant Anhalt at Johns Hopkins. Dr. Meyerle continues to supervise the only skin immunofluorescence laboratory in the Department of Defense at Walter Reed National Military Medical Center, which serves as a platform for his research in immunodermatology.
The National Capital Consortium has one of the largest dermatology residency program in the country with up to 18 residents going through training at any time. Dr. Meyerle has served as the Director of the Dermatology Residency Training program since 2014.
- Total-Body Photography in Skin Cancer Screening: The Clinical Utility of Standardized Imaging. Cutis, 2017 May; 99:312-316 .
- False-Negative Direct Immunofluorescence Testing in Vancomycin-Induced Linear IgA Bullous Dermatosis: A Diagnostic Pitfall. J Cutan Pathol. 2016 Sep;43(9):802-4.
- Teaching the KOH prep: A Disappearing Clinical Art Form. Cutis. 2015 Aug;96(2); 109-12.
- The Utilization of Teledermatology by the U.S. Military in a Deployed Setting, Mil Med. 2014 Nov; 179(11): 1347-1353.
- Bullous Systemic Lupus Erythematosus: A review and update to diagnosis and treatment, American Journal of Clinical Dermatology. 2014 Oct 31.
- Amputation stump: Privileged harbor for infections, tumors, and immune disorders, Clin Dermatol. 2014 Sep-Oct; 32(5):670-7.
- Alteration of Skin Properties with Autologous Dermal Fibroblasts, Int J Mol Sci. 2014 May 13, 15(5):8407-27.
- The Use of Dermatologic Simulation Platforms in Medical Education, Derm Surg. 2014;1–9.
- High prevalence of stump dermatoses 38 years or more after amputation. Arch Dermatol, 2012 Nov 1; 148 (11): 1283-6.
- Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies. J Am Acad Dermatol. Jan 2007 Vol 56(1): 153-9.